These are the headlines you Need2Know:
* **Tamer Hurricane Season Expected:**
The 2018 hurricane season is shaping up to be "below-normal.” Experts with NOAA now predict nine to 13 named storms ー maybe only two major hurricanes of Category 3 strength or higher. Last year there were 17 named storms, and three major hurricanes hit U.S. soil. For more on the condition of the storm, [click here](https://www.cnn.com/2018/08/09/us/noaa-hurricane-season-forecast-wxc/index.html).
* **Space Forces Needs a Logo and a Release Date:**
Vice President Mike Pence says the Pentagon is working to create Space Force, a sixth armed service to beef up military capabilities in space and help protect satellites. The biggest rivals in space are China and Russia. Congress needs to authorize and fund the force. Vote on the logo [here](https://arstechnica.com/tech-policy/2018/08/trump-wants-campaign-donors-to-vote-on-the-logo-for-the-space-force/), and read more [here](https://www.nytimes.com/2018/08/09/us/politics/trump-pence-space-force.html).
* **New NFL Season, More Protests:**
Several players took a knee, raised their fists or stayed off the field during the national anthem at last night’s preseason games. The NFL recently announced a policy that all players must stand for the national anthem, or remain in the locker room without penalty. But that policy is currently on hold. For more on this story, [click here](https://www.nbcnews.com/news/us-news/some-nfl-players-kneel-or-raise-fists-during-anthem-preseason-n899481).
* **A Potential 2020 Run for Stormy Daniels's Lawyer:**
Michael Avenatti, the lawyer for the adult entertainment start Stephanie Clifford, also known as Stormy Daniels, said he might run for president. Known as one of President Trump’s most outspoken critics in his capacity as Clifford's lawyer, Avenatti has also discussed his interest in challenging Trump on policies such as immigration. For more, check out [POLITICO](https://www.politico.com/story/2018/08/10/michael-avenatti-presidential-run-iowa-2020-771291).
Cheddar's Jill Wagner gets into the latest.
Subscribe to the Need2Know newsletter [here](https://theneed2know.com).
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Direct health care company Nomi Health recently raised $110 million in a Series A round. Nomi Health lets public and private organizations directly purchase healthcare at reduced costs, and pay providers in real-time. It also delivers healthcare directly to under-served communities via its fleet of mobile care units, which the company says is the largest in the country. Nomi Health says its mission is to improve the health care experience for all Americans. Nomi Health CEO Mark Newman joined Cheddar News' Closing Bell to discuss.
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
The boys discuss President Biden's plans to send out free rapid tests as the testing supply chain starts to buckle ahead of the holidays. Also, why aren't Americans having more babies, and The Matrix returns.
NASA is launching its new generation of space telescopes just before Christmas. The James Webb Space Telescope, set to launch on December 24th, will succeed the Hubble space telescope as the world's most powerful complex space observatory. The project has been 30 years in the making and is one of the most highly anticipated space science missions of the 21st century. Klaus Pontoppidan, astronomer and JWST Project Scientist at the Space Telescope Science Institute joined Cheddar's Opening Bell to discuss.
With Omicron becoming the dominant COVID-19 variant in the U.S., President Joe Biden announced that he will make 500 million rapid tests available to Americans in January 2022. Cheddar News speaks with Dr. Shereef Elnahal, President and CEO of University Hospital why testing is key to combatting the spread of the virus.
